BLUE Jan 2024 5.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Alla chiusura: 11:06AM EDT
Il grafico dei titoli non è supportato dal tuo browser attuale
| Chiusura precedente | 1,1000 |
| Aperto | 1,1000 |
| Denaro | 0,9000 |
| Lettera | 1,2000 |
| Prezzo d'esercizio | 5,00 |
| Scadenza | 2024-01-19 |
| Min-Max giorno | 1,1000 - 1,1000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 3,33k |
GlobeNewswireReal Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLOFLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to provide multiple health plans with access to an innovative, outcomes-based agreement for ZYNTEGLO® (betibeglogene autotem